Singapore, Singapore

Roy Soumyajit

This inventor holds 1 USPTO granted patent. Top assignee: International Business Machines Corporation. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roy Soumyajit: Innovator in Endpoint Compliance Management

Introduction

Roy Soumyajit is a notable inventor based in Singapore, SG. He has made significant contributions to the field of technology, particularly in endpoint compliance management. With a focus on ensuring that devices meet compliance standards, his work is crucial in today's digital landscape.

Latest Patents

Roy Soumyajit holds 1 patent for his invention titled "Endpoint Access Manager." This patent discloses a method, computer program product, and system for determining whether an endpoint meets compliance standards. The method involves processors receiving an endpoint certificate associated with a device requesting access to a resource. It includes determining the compliance level of the endpoint device and validating its credentials. Ultimately, the system assesses whether the endpoint device meets compliance standards based on the endpoint certificate, the determined compliance level, and the credentials.

Career Highlights

Roy is currently employed at International Business Machines Corporation, commonly known as IBM. His role at IBM allows him to work on innovative solutions that enhance security and compliance in technology.

Collaborations

Throughout his career, Roy has collaborated with talented individuals such as Ken Yian Chow and Guoguang Jason Lu. These collaborations have contributed to the development of advanced technologies and solutions in the industry.

Conclusion

Roy Soumyajit is a distinguished inventor whose work in endpoint compliance management is paving the way for more secure digital environments. His contributions to IBM and the technology sector are noteworthy and impactful.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…